nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—hepatitis B	0.767	1	CbGaD
Montelukast—Sinus headache—Telbivudine—hepatitis B	0.0084	0.0423	CcSEcCtD
Montelukast—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.00573	0.0288	CcSEcCtD
Montelukast—Skin infection—Lamivudine—hepatitis B	0.00511	0.0257	CcSEcCtD
Montelukast—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00477	0.024	CcSEcCtD
Montelukast—Rhinorrhoea—Telbivudine—hepatitis B	0.00338	0.017	CcSEcCtD
Montelukast—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00325	0.0164	CcSEcCtD
Montelukast—Suicide—Lamivudine—hepatitis B	0.00297	0.015	CcSEcCtD
Montelukast—SLCO2B1—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00288	0.0876	CbGpPWpGaD
Montelukast—ALOX5—Eicosanoid Synthesis—GGT2—hepatitis B	0.00276	0.0841	CbGpPWpGaD
Montelukast—Suicide attempt—Lamivudine—hepatitis B	0.00272	0.0137	CcSEcCtD
Montelukast—Completed suicide—Lamivudine—hepatitis B	0.00262	0.0132	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00208	0.0105	CcSEcCtD
Montelukast—Pancreatitis—Entecavir—hepatitis B	0.00205	0.0103	CcSEcCtD
Montelukast—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.002	0.0101	CcSEcCtD
Montelukast—Upper respiratory tract infection—Entecavir—hepatitis B	0.00194	0.00978	CcSEcCtD
Montelukast—Rhinorrhoea—Lamivudine—hepatitis B	0.0019	0.00959	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00179	0.00901	CcSEcCtD
Montelukast—Cramp muscle—Telbivudine—hepatitis B	0.00179	0.00901	CcSEcCtD
Montelukast—Nasopharyngitis—Telbivudine—hepatitis B	0.00178	0.00895	CcSEcCtD
Montelukast—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00177	0.00892	CcSEcCtD
Montelukast—Hepatobiliary disease—Entecavir—hepatitis B	0.00176	0.00888	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00175	0.00882	CcSEcCtD
Montelukast—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00172	0.00866	CcSEcCtD
Montelukast—Influenza—Telbivudine—hepatitis B	0.00172	0.00865	CcSEcCtD
Montelukast—Viral infection—Lamivudine—hepatitis B	0.00171	0.0086	CcSEcCtD
Montelukast—Bone disorder—Lamivudine—hepatitis B	0.00171	0.0086	CcSEcCtD
Montelukast—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00171	0.00859	CcSEcCtD
Montelukast—Hepatitis—Entecavir—hepatitis B	0.00167	0.00842	CcSEcCtD
Montelukast—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00163	0.00822	CcSEcCtD
Montelukast—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00162	0.00816	CcSEcCtD
Montelukast—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00161	0.00812	CcSEcCtD
Montelukast—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0016	0.00808	CcSEcCtD
Montelukast—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0016	0.00806	CcSEcCtD
Montelukast—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0016	0.00804	CcSEcCtD
Montelukast—Vasculitis—Lamivudine—hepatitis B	0.00158	0.00796	CcSEcCtD
Montelukast—Immune system disorder—Entecavir—hepatitis B	0.00151	0.00761	CcSEcCtD
Montelukast—Neuropathy peripheral—Telbivudine—hepatitis B	0.0015	0.00756	CcSEcCtD
Montelukast—Wheezing—Lamivudine—hepatitis B	0.0015	0.00754	CcSEcCtD
Montelukast—Mental disorder—Entecavir—hepatitis B	0.00147	0.00738	CcSEcCtD
Montelukast—ALOX5—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—hepatitis B	0.00145	0.0443	CbGpPWpGaD
Montelukast—Neuropathy—Lamivudine—hepatitis B	0.00145	0.00729	CcSEcCtD
Montelukast—Hepatobiliary disease—Telbivudine—hepatitis B	0.00145	0.00729	CcSEcCtD
Montelukast—Hepatitis—Telbivudine—hepatitis B	0.00137	0.00692	CcSEcCtD
Montelukast—Hypoaesthesia—Telbivudine—hepatitis B	0.00137	0.00689	CcSEcCtD
Montelukast—Pharyngitis—Telbivudine—hepatitis B	0.00136	0.00687	CcSEcCtD
Montelukast—Connective tissue disorder—Telbivudine—hepatitis B	0.00135	0.0068	CcSEcCtD
Montelukast—ALOX5—Eicosanoid Synthesis—GGT1—hepatitis B	0.00131	0.0398	CbGpPWpGaD
Montelukast—Sleep disorder—Lamivudine—hepatitis B	0.00129	0.00651	CcSEcCtD
Montelukast—Gastroenteritis—Lamivudine—hepatitis B	0.00126	0.00636	CcSEcCtD
Montelukast—Cough—Adefovir Dipivoxil—hepatitis B	0.00124	0.00624	CcSEcCtD
Montelukast—Mediastinal disorder—Telbivudine—hepatitis B	0.00124	0.00624	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00123	0.0062	CcSEcCtD
Montelukast—Injury—Lamivudine—hepatitis B	0.00122	0.00613	CcSEcCtD
Montelukast—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00121	0.00609	CcSEcCtD
Montelukast—SLCO2B1—Transport of organic anions—ALB—hepatitis B	0.00121	0.0367	CbGpPWpGaD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0012	0.00605	CcSEcCtD
Montelukast—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.0012	0.0365	CbGpPWpGaD
Montelukast—Anaphylactic shock—Entecavir—hepatitis B	0.00119	0.00599	CcSEcCtD
Montelukast—Infection—Entecavir—hepatitis B	0.00118	0.00595	CcSEcCtD
Montelukast—Thirst—Lamivudine—hepatitis B	0.00118	0.00592	CcSEcCtD
Montelukast—Nervous system disorder—Entecavir—hepatitis B	0.00117	0.00587	CcSEcCtD
Montelukast—Skin disorder—Entecavir—hepatitis B	0.00115	0.00581	CcSEcCtD
Montelukast—Muscle spasms—Telbivudine—hepatitis B	0.00115	0.00579	CcSEcCtD
Montelukast—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00114	0.00573	CcSEcCtD
Montelukast—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00114	0.00572	CcSEcCtD
Montelukast—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00113	0.00567	CcSEcCtD
Montelukast—Insomnia—Entecavir—hepatitis B	0.00108	0.00541	CcSEcCtD
Montelukast—Somnolence—Entecavir—hepatitis B	0.00106	0.00532	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00106	0.00532	CcSEcCtD
Montelukast—Dyspepsia—Entecavir—hepatitis B	0.00105	0.00527	CcSEcCtD
Montelukast—Cough—Telbivudine—hepatitis B	0.00104	0.00526	CcSEcCtD
Montelukast—Gastrointestinal disorder—Entecavir—hepatitis B	0.00103	0.00517	CcSEcCtD
Montelukast—Fatigue—Entecavir—hepatitis B	0.00103	0.00516	CcSEcCtD
Montelukast—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00102	0.00514	CcSEcCtD
Montelukast—Myalgia—Telbivudine—hepatitis B	0.00102	0.00513	CcSEcCtD
Montelukast—Arthralgia—Telbivudine—hepatitis B	0.00102	0.00513	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00101	0.00509	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00101	0.00508	CcSEcCtD
Montelukast—Cramp muscle—Lamivudine—hepatitis B	0.00101	0.00508	CcSEcCtD
Montelukast—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.001	0.00504	CcSEcCtD
Montelukast—Nasopharyngitis—Lamivudine—hepatitis B	0.001	0.00504	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000988	0.00497	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—GGT2—hepatitis B	0.000977	0.0297	CbGpPWpGaD
Montelukast—Gastrointestinal pain—Entecavir—hepatitis B	0.000972	0.00489	CcSEcCtD
Montelukast—Influenza—Lamivudine—hepatitis B	0.000968	0.00487	CcSEcCtD
Montelukast—Nervous system disorder—Telbivudine—hepatitis B	0.000958	0.00482	CcSEcCtD
Montelukast—Thrombocytopenia—Telbivudine—hepatitis B	0.000956	0.00481	CcSEcCtD
Montelukast—Pancreatitis—Lamivudine—hepatitis B	0.000949	0.00478	CcSEcCtD
Montelukast—Skin disorder—Telbivudine—hepatitis B	0.000949	0.00478	CcSEcCtD
Montelukast—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000949	0.00478	CcSEcCtD
Montelukast—Abdominal pain—Entecavir—hepatitis B	0.00094	0.00473	CcSEcCtD
Montelukast—Body temperature increased—Entecavir—hepatitis B	0.00094	0.00473	CcSEcCtD
Montelukast—Bronchitis—Lamivudine—hepatitis B	0.000931	0.00469	CcSEcCtD
Montelukast—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000917	0.00462	CcSEcCtD
Montelukast—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000917	0.00462	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00089	0.00448	CcSEcCtD
Montelukast—Insomnia—Telbivudine—hepatitis B	0.000883	0.00445	CcSEcCtD
Montelukast—Paraesthesia—Telbivudine—hepatitis B	0.000877	0.00442	CcSEcCtD
Montelukast—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.000875	0.0266	CbGpPWpGaD
Montelukast—Dyspepsia—Telbivudine—hepatitis B	0.00086	0.00433	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000856	0.00431	CcSEcCtD
Montelukast—Asthenia—Entecavir—hepatitis B	0.000853	0.00429	CcSEcCtD
Montelukast—Neuropathy peripheral—Lamivudine—hepatitis B	0.000846	0.00426	CcSEcCtD
Montelukast—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000843	0.00424	CcSEcCtD
Montelukast—Fatigue—Telbivudine—hepatitis B	0.000842	0.00424	CcSEcCtD
Montelukast—Jaundice—Lamivudine—hepatitis B	0.000841	0.00423	CcSEcCtD
Montelukast—Pain—Telbivudine—hepatitis B	0.000835	0.0042	CcSEcCtD
Montelukast—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000832	0.00419	CcSEcCtD
Montelukast—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000821	0.00413	CcSEcCtD
Montelukast—Hepatobiliary disease—Lamivudine—hepatitis B	0.000816	0.00411	CcSEcCtD
Montelukast—Epistaxis—Lamivudine—hepatitis B	0.000814	0.0041	CcSEcCtD
Montelukast—Diarrhoea—Entecavir—hepatitis B	0.000813	0.0041	CcSEcCtD
Montelukast—Sinusitis—Lamivudine—hepatitis B	0.00081	0.00408	CcSEcCtD
Montelukast—Gastrointestinal pain—Telbivudine—hepatitis B	0.000799	0.00402	CcSEcCtD
Montelukast—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000794	0.004	CcSEcCtD
Montelukast—Dizziness—Entecavir—hepatitis B	0.000786	0.00396	CcSEcCtD
Montelukast—Rhinitis—Lamivudine—hepatitis B	0.000777	0.00391	CcSEcCtD
Montelukast—Hepatitis—Lamivudine—hepatitis B	0.000775	0.0039	CcSEcCtD
Montelukast—Abdominal pain—Telbivudine—hepatitis B	0.000772	0.00389	CcSEcCtD
Montelukast—Body temperature increased—Telbivudine—hepatitis B	0.000772	0.00389	CcSEcCtD
Montelukast—Hypoaesthesia—Lamivudine—hepatitis B	0.000771	0.00388	CcSEcCtD
Montelukast—Pharyngitis—Lamivudine—hepatitis B	0.000769	0.00387	CcSEcCtD
Montelukast—Connective tissue disorder—Lamivudine—hepatitis B	0.000761	0.00383	CcSEcCtD
Montelukast—Vomiting—Entecavir—hepatitis B	0.000756	0.00381	CcSEcCtD
Montelukast—Rash—Entecavir—hepatitis B	0.00075	0.00377	CcSEcCtD
Montelukast—Dermatitis—Entecavir—hepatitis B	0.000749	0.00377	CcSEcCtD
Montelukast—Headache—Entecavir—hepatitis B	0.000745	0.00375	CcSEcCtD
Montelukast—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000738	0.00371	CcSEcCtD
Montelukast—Erythema multiforme—Lamivudine—hepatitis B	0.000733	0.00369	CcSEcCtD
Montelukast—Rash—Adefovir Dipivoxil—hepatitis B	0.000731	0.00368	CcSEcCtD
Montelukast—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000731	0.00368	CcSEcCtD
Montelukast—Headache—Adefovir Dipivoxil—hepatitis B	0.000727	0.00366	CcSEcCtD
Montelukast—ALOX5—Arachidonic acid metabolism—GGT1—hepatitis B	0.000726	0.0221	CbGpPWpGaD
Montelukast—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.000712	0.0217	CbGpPWpGaD
Montelukast—Nausea—Entecavir—hepatitis B	0.000706	0.00356	CcSEcCtD
Montelukast—Asthenia—Telbivudine—hepatitis B	0.000701	0.00353	CcSEcCtD
Montelukast—Immune system disorder—Lamivudine—hepatitis B	0.0007	0.00352	CcSEcCtD
Montelukast—Mediastinal disorder—Lamivudine—hepatitis B	0.000698	0.00352	CcSEcCtD
Montelukast—Pruritus—Telbivudine—hepatitis B	0.000691	0.00348	CcSEcCtD
Montelukast—Nausea—Adefovir Dipivoxil—hepatitis B	0.000689	0.00347	CcSEcCtD
Montelukast—Diarrhoea—Telbivudine—hepatitis B	0.000668	0.00336	CcSEcCtD
Montelukast—Muscle spasms—Lamivudine—hepatitis B	0.000648	0.00326	CcSEcCtD
Montelukast—Dizziness—Telbivudine—hepatitis B	0.000646	0.00325	CcSEcCtD
Montelukast—Tremor—Lamivudine—hepatitis B	0.000632	0.00318	CcSEcCtD
Montelukast—Vomiting—Telbivudine—hepatitis B	0.000621	0.00313	CcSEcCtD
Montelukast—Angioedema—Lamivudine—hepatitis B	0.000616	0.0031	CcSEcCtD
Montelukast—Rash—Telbivudine—hepatitis B	0.000616	0.0031	CcSEcCtD
Montelukast—Dermatitis—Telbivudine—hepatitis B	0.000615	0.0031	CcSEcCtD
Montelukast—Headache—Telbivudine—hepatitis B	0.000612	0.00308	CcSEcCtD
Montelukast—Cough—Lamivudine—hepatitis B	0.000589	0.00296	CcSEcCtD
Montelukast—Convulsion—Lamivudine—hepatitis B	0.000584	0.00294	CcSEcCtD
Montelukast—Nausea—Telbivudine—hepatitis B	0.00058	0.00292	CcSEcCtD
Montelukast—Myalgia—Lamivudine—hepatitis B	0.000574	0.00289	CcSEcCtD
Montelukast—Arthralgia—Lamivudine—hepatitis B	0.000574	0.00289	CcSEcCtD
Montelukast—Anxiety—Lamivudine—hepatitis B	0.000572	0.00288	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00057	0.00287	CcSEcCtD
Montelukast—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.000567	0.0172	CbGpPWpGaD
Montelukast—Oedema—Lamivudine—hepatitis B	0.00055	0.00277	CcSEcCtD
Montelukast—Anaphylactic shock—Lamivudine—hepatitis B	0.00055	0.00277	CcSEcCtD
Montelukast—Infection—Lamivudine—hepatitis B	0.000547	0.00275	CcSEcCtD
Montelukast—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.000542	0.0165	CbGpPWpGaD
Montelukast—Nervous system disorder—Lamivudine—hepatitis B	0.00054	0.00272	CcSEcCtD
Montelukast—Thrombocytopenia—Lamivudine—hepatitis B	0.000539	0.00271	CcSEcCtD
Montelukast—Skin disorder—Lamivudine—hepatitis B	0.000535	0.00269	CcSEcCtD
Montelukast—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000522	0.0159	CbGpPWpGaD
Montelukast—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000501	0.00252	CcSEcCtD
Montelukast—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000501	0.0152	CbGpPWpGaD
Montelukast—Insomnia—Lamivudine—hepatitis B	0.000498	0.00251	CcSEcCtD
Montelukast—Paraesthesia—Lamivudine—hepatitis B	0.000494	0.00249	CcSEcCtD
Montelukast—Somnolence—Lamivudine—hepatitis B	0.000489	0.00246	CcSEcCtD
Montelukast—Dyspepsia—Lamivudine—hepatitis B	0.000485	0.00244	CcSEcCtD
Montelukast—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000475	0.00239	CcSEcCtD
Montelukast—Fatigue—Lamivudine—hepatitis B	0.000475	0.00239	CcSEcCtD
Montelukast—Pain—Lamivudine—hepatitis B	0.000471	0.00237	CcSEcCtD
Montelukast—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000466	0.0142	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—GGT1—hepatitis B	0.000462	0.0141	CbGpPWpGaD
Montelukast—Gastrointestinal pain—Lamivudine—hepatitis B	0.00045	0.00227	CcSEcCtD
Montelukast—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000447	0.0136	CbGpPWpGaD
Montelukast—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.000442	0.0134	CbGpPWpGaD
Montelukast—Urticaria—Lamivudine—hepatitis B	0.000437	0.0022	CcSEcCtD
Montelukast—Abdominal pain—Lamivudine—hepatitis B	0.000435	0.00219	CcSEcCtD
Montelukast—Body temperature increased—Lamivudine—hepatitis B	0.000435	0.00219	CcSEcCtD
Montelukast—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000425	0.0129	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.000424	0.0129	CbGpPWpGaD
Montelukast—Hypersensitivity—Lamivudine—hepatitis B	0.000406	0.00204	CcSEcCtD
Montelukast—Asthenia—Lamivudine—hepatitis B	0.000395	0.00199	CcSEcCtD
Montelukast—Pruritus—Lamivudine—hepatitis B	0.000389	0.00196	CcSEcCtD
Montelukast—Diarrhoea—Lamivudine—hepatitis B	0.000377	0.0019	CcSEcCtD
Montelukast—Dizziness—Lamivudine—hepatitis B	0.000364	0.00183	CcSEcCtD
Montelukast—Vomiting—Lamivudine—hepatitis B	0.00035	0.00176	CcSEcCtD
Montelukast—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000348	0.0106	CbGpPWpGaD
Montelukast—Rash—Lamivudine—hepatitis B	0.000347	0.00175	CcSEcCtD
Montelukast—Dermatitis—Lamivudine—hepatitis B	0.000347	0.00175	CcSEcCtD
Montelukast—Headache—Lamivudine—hepatitis B	0.000345	0.00174	CcSEcCtD
Montelukast—Nausea—Lamivudine—hepatitis B	0.000327	0.00165	CcSEcCtD
Montelukast—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.000315	0.00959	CbGpPWpGaD
Montelukast—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000303	0.00923	CbGpPWpGaD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—hepatitis B	0.000299	0.00911	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—F2—hepatitis B	0.000296	0.00901	CbGpPWpGaD
Montelukast—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000291	0.00886	CbGpPWpGaD
Montelukast—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000283	0.0086	CbGpPWpGaD
Montelukast—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00028	0.00852	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—GGT2—hepatitis B	0.000267	0.00813	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—GGT2—hepatitis B	0.000248	0.00754	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—ALB—hepatitis B	0.000246	0.00748	CbGpPWpGaD
Montelukast—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000237	0.00721	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—GGT2—hepatitis B	0.000234	0.00713	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000229	0.00697	CbGpPWpGaD
Montelukast—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000225	0.00686	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—IFNG—hepatitis B	0.000224	0.00683	CbGpPWpGaD
Montelukast—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000222	0.00677	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.000215	0.00653	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—F2—hepatitis B	0.000209	0.00636	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000208	0.00633	CbGpPWpGaD
Montelukast—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000203	0.00619	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.0002	0.0061	CbGpPWpGaD
Montelukast—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0002	0.00608	CbGpPWpGaD
Montelukast—CYSLTR1—blood—hepatitis B	0.000196	0.138	CbGeAlD
Montelukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000188	0.00573	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000187	0.00569	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000187	0.00568	CbGpPWpGaD
Montelukast—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000183	0.00558	CbGpPWpGaD
Montelukast—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000183	0.00556	CbGpPWpGaD
Montelukast—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000181	0.00551	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.000173	0.00527	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000166	0.00504	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000165	0.00501	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000161	0.00491	CbGpPWpGaD
Montelukast—CYP2C8—blood plasma—hepatitis B	0.000161	0.113	CbGeAlD
Montelukast—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.00016	0.00487	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CXCL10—hepatitis B	0.000158	0.00482	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.00015	0.00457	CbGpPWpGaD
Montelukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000149	0.00452	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—TNF—hepatitis B	0.000145	0.00442	CbGpPWpGaD
Montelukast—CYP2C9—blood plasma—hepatitis B	0.000143	0.1	CbGeAlD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000138	0.00421	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000134	0.00408	CbGpPWpGaD
Montelukast—PTGS1—blood plasma—hepatitis B	0.00013	0.0917	CbGeAlD
Montelukast—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.00013	0.00397	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.000128	0.00391	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—GGT1—hepatitis B	0.000126	0.00385	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—CCR5—hepatitis B	0.000123	0.00374	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RIT2—hepatitis B	0.000122	0.0037	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SAG—hepatitis B	0.000122	0.0037	CbGpPWpGaD
Montelukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000121	0.00368	CbGpPWpGaD
Montelukast—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000119	0.00363	CbGpPWpGaD
Montelukast—ALOX5—blood—hepatitis B	0.000119	0.0837	CbGeAlD
Montelukast—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000117	0.00357	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—IL6—hepatitis B	0.000117	0.00357	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—TP53—hepatitis B	0.000115	0.0035	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—GGT1—hepatitis B	0.000111	0.00337	CbGpPWpGaD
Montelukast—CYP3A4—blood plasma—hepatitis B	0.000109	0.0766	CbGeAlD
Montelukast—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000107	0.00324	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—F2—hepatitis B	0.000105	0.00321	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000104	0.00316	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKR1B1—hepatitis B	0.000102	0.0031	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	9.93e-05	0.00302	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	9.8e-05	0.00298	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GGT2—hepatitis B	9.78e-05	0.00298	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	9.73e-05	0.00296	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	9.7e-05	0.00295	CbGpPWpGaD
Montelukast—SLCO2B1—SLC-mediated transmembrane transport—ALB—hepatitis B	9.6e-05	0.00292	CbGpPWpGaD
Montelukast—ALOX5—liver—hepatitis B	9.3e-05	0.0654	CbGeAlD
Montelukast—CYSLTR1—GPCR downstream signaling—CXCL10—hepatitis B	8.95e-05	0.00272	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	8.84e-05	0.00269	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GGT2—hepatitis B	8.59e-05	0.00262	CbGpPWpGaD
Montelukast—CYP2A6—liver—hepatitis B	8.2e-05	0.0577	CbGeAlD
Montelukast—CYSLTR1—Signaling by GPCR—CXCL10—hepatitis B	8.13e-05	0.00247	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	8.09e-05	0.00246	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	7.89e-05	0.0024	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—GGT1—hepatitis B	7.57e-05	0.0023	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	7.4e-05	0.00225	CbGpPWpGaD
Montelukast—SLCO2B1—liver—hepatitis B	7.16e-05	0.0504	CbGeAlD
Montelukast—CYSLTR1—GPCR downstream signaling—CCR5—hepatitis B	6.94e-05	0.00211	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	6.41e-05	0.00195	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CCR5—hepatitis B	6.3e-05	0.00192	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	6.3e-05	0.00192	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—GGT1—hepatitis B	6.16e-05	0.00188	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—F2—hepatitis B	5.96e-05	0.00181	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP2A6—hepatitis B	5.92e-05	0.0018	CbGpPWpGaD
Montelukast—CYP2C8—blood—hepatitis B	5.89e-05	0.0414	CbGeAlD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.52e-05	0.00168	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—F2—hepatitis B	5.41e-05	0.00165	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GOT2—hepatitis B	5.36e-05	0.00163	CbGpPWpGaD
Montelukast—CYP2C9—blood—hepatitis B	5.23e-05	0.0368	CbGeAlD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.22e-05	0.00159	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	5.21e-05	0.00158	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	5.08e-05	0.00155	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ALB—hepatitis B	4.88e-05	0.00148	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL10—hepatitis B	4.8e-05	0.00146	CbGpPWpGaD
Montelukast—PTGS1—blood—hepatitis B	4.78e-05	0.0336	CbGeAlD
Montelukast—ALOX5—Metabolism—GOT1—hepatitis B	4.62e-05	0.00141	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GGT1—hepatitis B	4.62e-05	0.00141	CbGpPWpGaD
Montelukast—CYP2C8—liver—hepatitis B	4.61e-05	0.0324	CbGeAlD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.5e-05	0.00137	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKR1B1—hepatitis B	4.42e-05	0.00135	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—TGFB1—hepatitis B	4.25e-05	0.00129	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GGT2—hepatitis B	4.24e-05	0.00129	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.21e-05	0.00128	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKR1B1—hepatitis B	4.18e-05	0.00127	CbGpPWpGaD
Montelukast—CYP2C9—liver—hepatitis B	4.09e-05	0.0288	CbGeAlD
Montelukast—CYP3A4—Biological oxidations—GGT1—hepatitis B	4.06e-05	0.00124	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—IL2—hepatitis B	4.01e-05	0.00122	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GGT2—hepatitis B	4.01e-05	0.00122	CbGpPWpGaD
Montelukast—CYP3A4—blood—hepatitis B	3.99e-05	0.028	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—CCR5—hepatitis B	3.72e-05	0.00113	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—hepatitis B	3.64e-05	0.00111	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—F2—hepatitis B	3.19e-05	0.000972	CbGpPWpGaD
Montelukast—CYP3A4—liver—hepatitis B	3.12e-05	0.0219	CbGeAlD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.91e-05	0.000885	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKR1B1—hepatitis B	2.86e-05	0.000869	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GGT2—hepatitis B	2.74e-05	0.000833	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2A6—hepatitis B	2.57e-05	0.000782	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—hepatitis B	2.46e-05	0.000749	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.39e-05	0.000729	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.37e-05	0.00072	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKR1B1—hepatitis B	2.32e-05	0.000707	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GOT2—hepatitis B	2.32e-05	0.000707	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GGT2—hepatitis B	2.23e-05	0.000678	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GOT2—hepatitis B	2.2e-05	0.000668	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—hepatitis B	2.15e-05	0.000655	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—hepatitis B	2.14e-05	0.000652	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CTNNB1—hepatitis B	2.08e-05	0.000632	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1A—hepatitis B	2.03e-05	0.000618	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—hepatitis B	2.02e-05	0.000616	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NFKB1—hepatitis B	2.01e-05	0.000613	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GOT1—hepatitis B	2e-05	0.00061	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GGT1—hepatitis B	2e-05	0.00061	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GOT1—hepatitis B	1.9e-05	0.000577	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GGT1—hepatitis B	1.9e-05	0.000577	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—hepatitis B	1.88e-05	0.000571	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.83e-05	0.000556	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—hepatitis B	1.68e-05	0.000511	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2A6—hepatitis B	1.66e-05	0.000505	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.55e-05	0.000471	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.53e-05	0.000467	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GOT2—hepatitis B	1.5e-05	0.000457	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GGT2—hepatitis B	1.47e-05	0.000447	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—hepatitis B	1.38e-05	0.00042	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.35e-05	0.000411	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GGT1—hepatitis B	1.3e-05	0.000394	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GOT1—hepatitis B	1.3e-05	0.000394	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—hepatitis B	1.26e-05	0.000385	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.26e-05	0.000383	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GOT2—hepatitis B	1.22e-05	0.000372	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.18e-05	0.000359	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—hepatitis B	1.07e-05	0.000325	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GOT1—hepatitis B	1.05e-05	0.000321	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GGT1—hepatitis B	1.05e-05	0.000321	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—hepatitis B	1.01e-05	0.000307	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.6e-06	0.000292	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2A6—hepatitis B	8.9e-06	0.000271	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—hepatitis B	8.14e-06	0.000248	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GOT2—hepatitis B	8.05e-06	0.000245	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—hepatitis B	7.69e-06	0.000234	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GGT1—hepatitis B	6.95e-06	0.000212	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GOT1—hepatitis B	6.95e-06	0.000212	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—hepatitis B	6.89e-06	0.00021	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—hepatitis B	5.61e-06	0.000171	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—hepatitis B	5.26e-06	0.00016	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—hepatitis B	4.28e-06	0.00013	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—hepatitis B	3.7e-06	0.000113	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—hepatitis B	2.82e-06	8.59e-05	CbGpPWpGaD
